These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 1426030

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. A long-term receptor stimulation is requisite for angiotensin II-dependent DNA synthesis in vascular smooth muscle cells from spontaneously hypertensive rats.
    Itazaki K, Hara M, Itoh N, Fujimoto M.
    Eur J Pharmacol; 1995 Nov 30; 291(3):417-25. PubMed ID: 8719428
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Angiotensin II-induced responses in vascular smooth muscle cells: inhibition by non-peptide receptor antagonists.
    Catalioto RM, Porchia R, Renzetti AR, Criscuoli M, Subissi A, Giachetti A.
    Eur J Pharmacol; 1995 Jul 14; 280(3):285-92. PubMed ID: 8566096
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effect of SR 47436, a novel angiotensin II AT1 receptor antagonist, on human vascular smooth muscle cells in vitro.
    Herbert JM, Delisée C, Dol F, Schaeffer P, Cazaubon C, Nisato D, Chatelain P.
    Eur J Pharmacol; 1994 Jan 14; 251(2-3):143-50. PubMed ID: 8149971
    [Abstract] [Full Text] [Related]

  • 9. ANG II receptor expression and function during phenotypic modulation of rat aortic smooth muscle cells.
    Corriu C, André P, Schott C, Michel M, Stoclet JC.
    Am J Physiol; 1994 Feb 14; 266(2 Pt 2):H631-6. PubMed ID: 8141364
    [Abstract] [Full Text] [Related]

  • 10. Effects of BAY 10-6734 (Embusartan), a new angiotensin II type I receptor antagonist, on vascular smooth muscle cell growth.
    Iouzalen L, Stepien O, Marche P.
    J Pharmacol Exp Ther; 1999 Apr 14; 289(1):181-7. PubMed ID: 10087002
    [Abstract] [Full Text] [Related]

  • 11. HR 720, a novel angiotensin receptor antagonist inhibits the angiotensin II-induced trophic effects, fibronectin release and fibronectin-EIIIA+ expression in rat aortic vascular smooth muscle cells in vitro.
    Dunn FW, Roux MH, Farhadian F, Sabri K, Ossart C, Samuel JL, Rappaport L, Hamon G.
    J Pharmacol Exp Ther; 1997 Jan 14; 280(1):447-53. PubMed ID: 8996227
    [Abstract] [Full Text] [Related]

  • 12. Effect of angiotensin II receptor blocker on angiotensin II stimulated DNA synthesis of cultured human aortic smooth muscle cells.
    Makita S, Nakamura M, Yoshida H, Hiramori K.
    Life Sci; 1995 Jan 14; 56(20):PL383-8. PubMed ID: 7723594
    [Abstract] [Full Text] [Related]

  • 13. BMS-180560, an insurmountable inhibitor of angiotensin II-stimulated responses: comparison with losartan and EXP3174.
    Dickinson KE, Cohen RB, Skwish S, Delaney CL, Serafino RP, Poss MA, Gu Z, Ryono DE, Moreland S, Powell JR.
    Br J Pharmacol; 1994 Sep 14; 113(1):179-89. PubMed ID: 7812609
    [Abstract] [Full Text] [Related]

  • 14. Nonpeptide angiotensin II receptor antagonists: insurmountable angiotensin II antagonism of EXP3892 is reversed by the surmountable antagonist DuP 753.
    Wong PC, Timmermans PB.
    J Pharmacol Exp Ther; 1991 Jul 01; 258(1):49-57. PubMed ID: 2072311
    [Abstract] [Full Text] [Related]

  • 15. Tranilast antagonizes angiotensin II and inhibits its biological effects in vascular smooth muscle cells.
    Miyazawa K, Fukuyama J, Misawa K, Hamano S, Ujiie A.
    Atherosclerosis; 1996 Apr 05; 121(2):167-73. PubMed ID: 9125291
    [Abstract] [Full Text] [Related]

  • 16. Angiotensin II-1 receptors mediate both vasoconstrictor and hypertrophic responses in rat aortic smooth muscle cells.
    Chiu AT, Roscoe WA, McCall DE, Timmermans PB.
    Receptor; 1991 Apr 05; 1(3):133-40. PubMed ID: 1843203
    [Abstract] [Full Text] [Related]

  • 17. Different types of receptor interaction of peptide and nonpeptide angiotensin II antagonists revealed by receptor binding and functional studies.
    Wienen W, Mauz AB, Van Meel JC, Entzeroth M.
    Mol Pharmacol; 1992 Jun 05; 41(6):1081-8. PubMed ID: 1614410
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effects of captopril, losartan, and nifedipine on cell hypertrophy of cultured vascular smooth muscle from hypertensive Ren-2 transgenic rats.
    Peiró C, Llergo JL, Angulo J, López-Novoa JM, Rodríguez-López A, Rodríguez-Mañas L, Sánchez-Ferrer CF.
    Br J Pharmacol; 1997 Aug 05; 121(7):1438-44. PubMed ID: 9257925
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.